SPECTRUM PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Spectrum Pharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q1 2023.
  • Spectrum Pharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2023 was $1.52M, a 28% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $1.52M -$589K -28% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.69M -$811K -32.4% Dec 31, 2022 10-Q 2023-05-11
Q3 2022 $1.87M -$1.01M -35.1% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.7M +$271K +18.9% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $2.11M +$283K +15.5% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $2.51M +$258K +11.5% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $2.88M +$219K +8.23% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $1.43M -$1.64M -53.3% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.82M -$1.64M -47.4% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $2.25M -$1.56M -41% Dec 31, 2020 10-K 2022-03-18
Q3 2020 $2.66M -$869K -24.6% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $3.07M -$774K -20.1% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $3.47M -$307K -8.14% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $3.81M +$3.81M Dec 31, 2019 10-K 2021-03-31
Q3 2019 $3.53M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $3.84M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $3.77M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $0 Dec 31, 2018 10-Q 2019-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.